Summary and conclusions Estimation of plasma glucose in home blood samples is needed to improve diabetic control. Sufficiently precise measurements on capillary blood were obtained by (a) storing Reflotest glucose-oxidase strips in a desiccant container before reading and (b) collecting blood samples into a simple vacuum bottle containing potassium fluoride (assay of sodium content indicating volume of plasma collected). The precision of the methods (+ 1 SD) was C0 35 mmol/l ( 63 mg/100 ml). Clinical reliability was assessed by measuring the basal plasma glucose concentration at home on different mornings in patients with maturity-onset diabetes, the day-to-day variation
(1 SD) being fi0O73 and f092 mmol/l (=132 and _ 16 6 mg/100 ml) respectively. The mean basal plasma glucose concentration in all 84 patients with maturity-onset diabetes from three general practices was 8 mmol/l (144 mg/100 ml), 44 of the values exceeding 6 mmol/l (108 mg/100 ml). Improving control by monitoring the basal plasma glucose concentration in maturity-onset diabetes might help to prevent diabetic complications.
Introduction
Current treatment of diabetes does little to prevent complications, possibly because control based on urine glucose estimation is not precise enough. Improved control might be gained by regular measurement of the plasma glucose concentration at home. In maturity-onset diabetes a logical aim is to lower the basal plasma glucose concentration to normal,' while in insulin-dependent diabetes additional plasma glucose estimations after meals are needed to determine the requirement for insulin before meals. Although plasma glucose may be estimated at home by patients with glucose-oxidase strips and a colorimeter,3 'the need for equipment means that the method i not widely applicable.
In this paper we examine alternative methods for home capillary blood sampling, including a stored glucose-oxidase strip and a new collector bottle. Their clinical use has been validated by fasting plasma glucose measurements in patients with maturity-onset diabetes.
Methods
Reflotest- Vacuiiiii collector bottles-Small polyethylene bottles containing approximately 1 2 ml Analar potassium fluoride 100 g/l are sealed after being compressed to produce a partial vacuum. The bottle top, which is covered by a screw cap, contains a shallow depression. After pricking a finger the patient puts a drop of blood into the depression. He then pricks through the drop (with the lancet used to prick his finger) to make a small hole, and when the lancet is withdrawn the blood is automatically sucked into the container. The screw cap is replaced and the bottle sent to the laboratory. The sodium concentration (allowance being made for sodium in the Analar potassium fluoride) indicates the amount of plasma in the container, the plasma sodium concentration being taken as 140 mmol (mEq)/l. The sodium content of the collector fluid is measured in 100 ,l aliquots with a spectrophotometer. If the sodium content indicates that less than 10 pl of blood is present insufficient blood has been taken for precise assay. The glucose concentration is assayed with glucose oxidase in 300 ul aliquots. To allow for the glucose content of the red cells diffusing into the collector fluid, the plasma glucose concentration is estimated by multiplying the collector fluid glucose content by 0 75 (a packed cell volume of 0-4 (40",), red cell glucose space of 60",,; and sodium content of 8 mmol/l' being assumed). If a patient is anaemic, with a packed cell volume of 0-3, the plasma glucose concentration is underestimated by I11
Other collectors-In a preliminary study patients were asked to collect blood into (1) simple capillary tubes coated with sodium fluoride, (2) capillary vessels with sodium fluoride that widen to collect blood (Sarstedt), (3) wide-mouthed (0-8 cm) tubes containing sodium fluoride into which blood could be "milked" from the finger (Sarstedt), and (4) Glucose concentration was measured with the manual Boehringer kit, and sodium concentration with a Unicam SP9Oa atomic absorption spectrophotometer. The precision of methods and day-to-day variation in patients with fasting plasma glucose concentrations below 8 mmol/l (144 mg/l100 ml) were obtained from two values (SD = X 'E(diff)2/2n). Statistical methods used included linear regression by least-square analysis and the paired t test.
Results
Reflotest-Blood samples were placed on Reflotest strips in the laboratory and read in the Reflomat meter over five days. After storage at 4°, 20°, and 35"C in a desiccator the plasma glucose estimations fell appreciably only at the higher temperature and higher glucose concentrations (fig 1) . When stored in a normal atmosphere there was a greater reduction. When the strips were left in 1000 humidity the estimation was more dependent on temperature than on blood glucose concentration. Leaving the strips in sunlight deepened the colour. Thus for routine use the strips need to be transported in a light-proof container with desiccant. Fig 2 shows the stability of the mean of duplicate estimations on blood samples taken in a diabetic clinic and read at daily intervals for seven days after storage in desiccator tubes. Analysis of duplicates showed a precision of +0-25 mmol/l (±4-5 mg/ 100 ml) at one minute, and on subsequent days this rose to +0 35 mmol/l (+6-3 mg/100 ml). The accuracy was estimated by comparing results with direct plasma glucose assay. For values below 8 mmol/l (144 mg/100 ml) the standard deviation of the difference between these estimations was +0 47 mmol/l (+85 mg/100 ml) (n=89; mean 5-9 mmol/l-106 mg/100 ml), and for values above 8 mmol/l, +0-85 mmol/l (+15-3 mg/100 ml) (n=56; mean 109 mmol/l-196 mg/100 ml).
Vacuum collector bottles-There was no difference in results from replicate blood aliquots assayed between five minutes and five days after addition to the collector bottles. Precision, estimated from duplicate samples, was (+1 SD) +0 31 mmol/l (+5 6 mg/100 ml The accuracy was estimated by comparing the results with direct plasma glucose assay. For values below 8 mmol/l the standard deviation of the difference between these estimations was +0-61 mmol/l (+110 mg/100 ml) (n=92; mean 5-7 mmol/l-103 mg/100 ml), and for values above 8 mmol/l, 1-37 mmol/l (+24 7 mg/100 ml) (n=56; mean 108 mmol/1-195 mg/lOG ml).
Other collectors-Simple capillary tubes proved too fragile for general use. The Sarstedt "flask" capillary tube and "milking" blood into a wide-mouthed tube were too messy for routine use. In all these methods it is difficult to ensure mixing of the blood with the fluoride to prevent glycolysis. The Unopettes were highly satisfactory when used by technicians (r=0 94 compared with results of direct plasma glucose assay) and some patients; but most patients had difficulty in transferring the blood to the diluent in the container, and there was no means of determining whether the capillary tube had been insufficiently filled with blood or some blood or diluent had been spilt.
CLINICAL STUDIES
The mean fasting plasma glucose concentration in all 84 diabetic patients was 8 mmol/l (144 mg/100 ml); in 44 of them the value exceeded 6 mmol/l (108 mg/100 ml). Sixty-three patients managed to take blood samples at home. Of 662 home blood samples, 179 (27 o) Reflotest strips.had to be rejected because the drops of blood had not been correctly applied, and 53 (80U) collector bottles contained less than 10 ul of blood. In each case inadequate results probably arose in part from the use of both methods on the same occasion.
The table shows the day-to-day variation of the estimated fasting plasma glucose concentration in patients with values below 8 mmol l. Conversion: SI to traditional uinits-Plasma glucose: 1 mmol/l 18 mg'100 ml.
There was little difference in precision between the methods. The disparity between home Reflotest and clinic fluoride results was slightly greater than would be expected from the precision of each, probably reflecting the inability of some patients to time accurately the contact of blood on the Reflotest strip. Figure 3 shows the fasting plasma glucose concentrations measured in collector bottle samples at home and in the clinic, the latter being a mean of 0 4 mmol/1 (7-2 mg/100 ml) higher than those taken at home (P < 0 005). (Blood glucose: 1 mmol/lI 18 mg/100 ml.) Discussion These simple methods of blood collection and transport provide sufficiently accurate results to permit clinical decisions on diabetic control. The changes in plasma glucose concentrations with treatment of diabetes are much greater than the small differences arising from storage of the Reflotest strips or from individual variation in plasma sodium concentration or packed cell volume affecting collector bottle results. The Reflotest method obviates the need for assessment in a laboratory, although the patient must be reliable enough to time accurately a drop of blood on the strip for one minute. The collector bottle has the advantage that the result is independent, of the patient's skill. Both methods are more acceptable to patients than taking blood samples, in the available capillary tubes, which tend to be either messy or too complicated for general use.
Many patients with maturity-onset diabetes who are thought to be "well controlled" because of the absence of glycosuria may have pronounced basal hyperglycaemia. Monitoring the fasting plasma glucose concentration would permit better control. The day-to-day variation measured by any of these methods exceeded the 4 0-3 mmol/l ( -5 4 mg/100 ml) (-, 1 SD) of mild diabetes under strictly basal conditions.7 This was probably due to varying "stress" factors, including exercise, on different mornings; but there was not a marked difference in fasting plasma glucose concentration between samples taken at home and in the clinic.
The day-to-day variation was sufficiently small, whether assessed in the clinic or at home by the transportable methods, for lowering the fasting plasma glucose to below 6 mmol/l (108 mg/100 ml) to be a reasonable aim in patients with maturityonset diabetes. In practice these patients can be most easily monitored at general practice surgeries, the fasting plasma glucose concentration being measured in a Reflomat. For patients unable to attend, however, either of the transportable methods may be used. Equally, these methods are suitable for monitoring control throughout the day in insulin-dependent diabetics during their normal routine.
